Skip to main content

Reproductive Markers in Alzheimer's Disease Progression: The Framingham Heart Study.

Publication ,  Journal Article
Ding, H; Li, Y; Ang, TFA; Liu, Y; Devine, S; Au, R; Doraiswamy, PM; Liu, C
Published in: J Prev Alzheimers Dis
2023

BACKGROUND: Reproductive status, such as the age of menarche or menopause, may be linked to cognitive abilities and risk for incident Alzheimer's disease (AD) but the evidence is conflicting. It is also not fully known if these factors interact with cortical beta-amyloid deposition. OBJECTIVES: To study the relationship between reproductive risks, sex hormone markers and risk for decline in specific cognitive domains in women. DESIGN, SETTING AND PARTICIPANTS: We analyzed the association of reproductive markers (age at menarche, number of births, age at menopause, sex hormone-binding globulin, estradiol, estrone, total testosterone, free testosterone) with incident AD and annualized cognitive decline in the community-based longitudinal Framingham Heart Study (FHS) Offspring women 60 years and older (n=772, mean age 68 years, mean follow-up 10.7 ± 3 years). We used the Cox proportional hazards regression model and linear regression model, adjusting for covariates. OUTCOME MEASURES: Incident AD dementia as well as the annualized change in memory, language, attention and executive functions. RESULTS: Older age at menopause was associated with a lower risk of incident AD dementia (p = 0.047, 6% lower risk per older year) after adjusting for baseline age, education, hormone therapy status, and MMSE score. Older age at menopause was significantly associated with a slower annualized decline in memory (beta = 0.085, p = 0.00059). The lower level of plasma Aβ42 was also associated with a higher risk of incident AD (HR = 0.97, 95% CI = 0.95, 0.99; p = 0.0039) but there was no significant interaction effect with age at menarche, age at menopause or plasma sex hormone levels. CONCLUSION: Younger age at menopause is a risk factor for late-life memory decline and incident AD. This risk appears to be independent of Aβ42 pathology. Further studies to understand the biological and social mechanisms underlying the differential effects of reproductive risks are warranted.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Prev Alzheimers Dis

DOI

EISSN

2426-0266

Publication Date

2023

Volume

10

Issue

3

Start / End Page

530 / 535

Location

Switzerland

Related Subject Headings

  • Testosterone
  • Longitudinal Studies
  • Humans
  • Gonadal Steroid Hormones
  • Female
  • Cognitive Dysfunction
  • Alzheimer Disease
  • Aged
  • 5204 Cognitive and computational psychology
  • 5202 Biological psychology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ding, H., Li, Y., Ang, T. F. A., Liu, Y., Devine, S., Au, R., … Liu, C. (2023). Reproductive Markers in Alzheimer's Disease Progression: The Framingham Heart Study. J Prev Alzheimers Dis, 10(3), 530–535. https://doi.org/10.14283/jpad.2023.28
Ding, H., Y. Li, T. F. A. Ang, Y. Liu, S. Devine, R. Au, P. M. Doraiswamy, and C. Liu. “Reproductive Markers in Alzheimer's Disease Progression: The Framingham Heart Study.J Prev Alzheimers Dis 10, no. 3 (2023): 530–35. https://doi.org/10.14283/jpad.2023.28.
Ding H, Li Y, Ang TFA, Liu Y, Devine S, Au R, et al. Reproductive Markers in Alzheimer's Disease Progression: The Framingham Heart Study. J Prev Alzheimers Dis. 2023;10(3):530–5.
Ding, H., et al. “Reproductive Markers in Alzheimer's Disease Progression: The Framingham Heart Study.J Prev Alzheimers Dis, vol. 10, no. 3, 2023, pp. 530–35. Pubmed, doi:10.14283/jpad.2023.28.
Ding H, Li Y, Ang TFA, Liu Y, Devine S, Au R, Doraiswamy PM, Liu C. Reproductive Markers in Alzheimer's Disease Progression: The Framingham Heart Study. J Prev Alzheimers Dis. 2023;10(3):530–535.

Published In

J Prev Alzheimers Dis

DOI

EISSN

2426-0266

Publication Date

2023

Volume

10

Issue

3

Start / End Page

530 / 535

Location

Switzerland

Related Subject Headings

  • Testosterone
  • Longitudinal Studies
  • Humans
  • Gonadal Steroid Hormones
  • Female
  • Cognitive Dysfunction
  • Alzheimer Disease
  • Aged
  • 5204 Cognitive and computational psychology
  • 5202 Biological psychology